Harish Nagaraj, Consultant and HOD Nuclear Medicine, MIC In-Charge at KUTRRH, shared a post on LinkedIn:
“Radiotheranostics is advancing rapidly, offering new hope for cancer patients by combining molecular imaging with targeted radiation to precisely detect and treat tumors. By using a single molecule to both visualize and treat cancer, it eliminates the trial-and-error approach of traditional oncology and spares healthy tissue from unnecessary damage.
For nations, investing in this field isn’t just about advancing science—it means strengthening a key pillar of modern, personalized medicine and improving patient survival. The second Radiotheranostics Summit, organized by the Oncidium foundation, will take place during the World Health Summit (WHS) Regional Meeting 2026 in Nairobi, bringing experts together to accelerate implementation and expand patient access.
Tuesday, April 28th, 3:30 – 5 PM, ROOM: CR 11″
More posts featuring Harish Nagaraj.